IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Long-Term Debt Repayments (2020 - 2023)

Updated

IRulya Therapeutics' Long-Term Debt Repayments was $6,000 in FY2023, down 87.8% from $49,000 in FY2022.

Analysis

IRulya Therapeutics (IRLA) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends

From FY2019 onward, IRulya Therapeutics has reported Long-Term Debt Repayments for 4 years.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of -67.8% (FY2019 to FY2023).
  • Per Business Quant data, Long-Term Debt Repayments in earlier years was $49,000 in FY2022, $34,000 in FY2020 (-93.9%) and $559,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 1.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 6,000.00
Dec 31, 2022 18,000.00
Sep 30, 2022 19,000.00
Jun 30, 2022 12,000.00
Dec 31, 2020 2,000.00
Jun 30, 2020 3,000.00
Mar 31, 2020 29,000.00
API Access

IRulya Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=IRLA&period=max&api_key=YOUR_API_KEY